NO960272L - Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme - Google Patents

Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme

Info

Publication number
NO960272L
NO960272L NO960272A NO960272A NO960272L NO 960272 L NO960272 L NO 960272L NO 960272 A NO960272 A NO 960272A NO 960272 A NO960272 A NO 960272A NO 960272 L NO960272 L NO 960272L
Authority
NO
Norway
Prior art keywords
oxathiolanes
processes
preparation
same
pharmaceutical compositions
Prior art date
Application number
NO960272A
Other languages
English (en)
Other versions
NO306299B1 (no
NO960272D0 (no
Inventor
Anne-Sophie Charvet-Faury
Michel Camplo
Jean-Louis Kraus
Original Assignee
Laphal Laboratoires Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laphal Laboratoires Sa filed Critical Laphal Laboratoires Sa
Publication of NO960272L publication Critical patent/NO960272L/no
Publication of NO960272D0 publication Critical patent/NO960272D0/no
Publication of NO306299B1 publication Critical patent/NO306299B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO960272A 1994-05-24 1996-01-23 Oksatiolaner og farmasöytiske preparater med antiviral virkning som inneholder de samme NO306299B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9406262A FR2720397B1 (fr) 1994-05-24 1994-05-24 Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.
PCT/FR1995/000683 WO1995032200A1 (fr) 1994-05-24 1995-05-24 Oxathiolanes, leur procede de preparation et les compositions pharmaceutiques qui en renferment

Publications (3)

Publication Number Publication Date
NO960272L true NO960272L (no) 1996-01-23
NO960272D0 NO960272D0 (no) 1996-01-23
NO306299B1 NO306299B1 (no) 1999-10-18

Family

ID=9463449

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960272A NO306299B1 (no) 1994-05-24 1996-01-23 Oksatiolaner og farmasöytiske preparater med antiviral virkning som inneholder de samme

Country Status (19)

Country Link
US (1) US5708000A (no)
EP (1) EP0733053A1 (no)
JP (1) JPH09502453A (no)
KR (1) KR100242891B1 (no)
CN (1) CN1080264C (no)
AP (1) AP612A (no)
AU (1) AU688052B2 (no)
BR (1) BR9506244A (no)
CA (1) CA2167930A1 (no)
CZ (1) CZ21996A3 (no)
FI (1) FI960316A (no)
FR (1) FR2720397B1 (no)
HU (1) HU219299B (no)
NO (1) NO306299B1 (no)
NZ (1) NZ287478A (no)
OA (1) OA10258A (no)
PL (1) PL181713B1 (no)
RU (1) RU2142462C1 (no)
WO (1) WO1995032200A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2720397B1 (fr) * 1994-05-24 1996-08-23 Laphal Laboratoires Sa Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.
IT1290447B1 (it) * 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
BR122018075478B8 (pt) * 2004-06-24 2023-10-31 Vertex Pharma moduladores de transportadores de cassete de ligação de atp
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US20090105272A1 (en) * 2005-12-24 2009-04-23 Grootenhuis Peter D J Prodrugs of modulators of ABC transporters
HUE049976T2 (hu) 2005-12-28 2020-11-30 Vertex Pharma N-[2,4-bisz(1,1-dimetil-etil)-5-hidroxi-fenil]-1,4-dihidro-4-oxo-kinolin-3-karboxamid amorf alakjának gyógyászati kompozíciói
PE20071025A1 (es) * 2006-01-31 2007-10-17 Mitsubishi Tanabe Pharma Corp Compuesto amina trisustituido
SG10201504084QA (en) 2009-03-20 2015-06-29 Vertex Pharma Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
CN109966264A (zh) 2012-02-27 2019-07-05 沃泰克斯药物股份有限公司 药物组合物及其施用
CN107250113B (zh) 2014-10-07 2019-03-29 弗特克斯药品有限公司 囊性纤维化跨膜传导调节蛋白的调节剂的共晶

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
DK0560794T3 (da) * 1990-11-13 1996-12-23 Iaf Biochem Int Substituerede 1,3-oxathiolaner med antivirale egenskaber
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
FR2720397B1 (fr) * 1994-05-24 1996-08-23 Laphal Laboratoires Sa Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.

Also Published As

Publication number Publication date
FI960316A0 (fi) 1996-01-23
NO306299B1 (no) 1999-10-18
HU219299B (en) 2001-03-28
FR2720397B1 (fr) 1996-08-23
EP0733053A1 (fr) 1996-09-25
FR2720397A1 (fr) 1995-12-01
PL312693A1 (en) 1996-05-13
PL181713B1 (en) 2001-09-28
BR9506244A (pt) 1997-08-12
HUT75112A (en) 1997-04-28
CA2167930A1 (fr) 1995-11-30
AU688052B2 (en) 1998-03-05
NO960272D0 (no) 1996-01-23
JPH09502453A (ja) 1997-03-11
CN1130906A (zh) 1996-09-11
CN1080264C (zh) 2002-03-06
AU2620995A (en) 1995-12-18
NZ287478A (en) 1997-09-22
FI960316A (fi) 1996-03-22
OA10258A (fr) 1997-10-07
US5708000A (en) 1998-01-13
KR100242891B1 (ko) 2000-03-02
RU2142462C1 (ru) 1999-12-10
AP612A (en) 1997-09-05
CZ21996A3 (en) 1996-05-15
WO1995032200A1 (fr) 1995-11-30
KR960703903A (ko) 1996-08-31
AP9600784A0 (en) 1996-04-30

Similar Documents

Publication Publication Date Title
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
DK0676409T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO993003L (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
NO991815L (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
NO20011216L (no) Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
NO20016038L (no) Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL140897A0 (en) Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL113103A0 (en) Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
NO20012727D0 (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
NO308362B1 (no) 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene
NO20001288D0 (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel
NO20003661D0 (no) Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
BR9507768A (pt) Composição farmacêutica
GB9310075D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002